11.41
Precedente Chiudi:
$11.48
Aprire:
$11.39
Volume 24 ore:
3.13M
Relative Volume:
0.68
Capitalizzazione di mercato:
$5.64B
Reddito:
$4.45B
Utile/perdita netta:
$205.00M
Rapporto P/E:
28.52
EPS:
0.4
Flusso di cassa netto:
$372.00M
1 W Prestazione:
-0.87%
1M Prestazione:
-0.17%
6M Prestazione:
-12.50%
1 anno Prestazione:
-28.55%
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
2500 INNOVATION WAY, GREENFIELD
Confronta ELAN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
ELAN
Elanco Animal Health Inc
|
11.41 | 5.64B | 4.45B | 205.00M | 372.00M | 0.40 |
![]()
ZTS
Zoetis Inc
|
174.29 | 78.63B | 9.15B | 2.43B | 2.31B | 5.32 |
![]()
HLN
Haleon Plc Adr
|
9.85 | 44.54B | 14.26B | 1.55B | 0 | 0.3383 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 42.61B | 30.25B | 1.37B | 5.08B | 0.4257 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.59 | 18.79B | 16.54B | -1.64B | 749.00M | -1.45 |
![]()
ITCI
Intra Cellular Therapies Inc
|
127.56 | 13.55B | 612.78M | -86.37M | -62.91M | -0.87 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-09 | Iniziato | UBS | Buy |
2024-12-02 | Iniziato | Leerink Partners | Market Perform |
2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
2023-12-19 | Iniziato | Jefferies | Buy |
2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
2022-07-21 | Downgrade | Goldman | Buy → Sell |
2022-07-12 | Iniziato | Piper Sandler | Neutral |
2021-11-18 | Iniziato | Morgan Stanley | Overweight |
2021-10-28 | Downgrade | Stifel | Buy → Hold |
2021-08-05 | Ripresa | Credit Suisse | Outperform |
2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
2021-04-15 | Iniziato | Stifel | Buy |
2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
2020-12-09 | Downgrade | Argus | Buy → Hold |
2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2020-08-13 | Ripresa | Credit Suisse | Neutral |
2020-08-04 | Ripresa | Goldman | Buy |
2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2020-01-10 | Iniziato | Raymond James | Mkt Perform |
2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2019-09-23 | Iniziato | Barclays | Overweight |
2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
2019-05-23 | Iniziato | Guggenheim | Neutral |
2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
2019-02-12 | Iniziato | William Blair | Mkt Perform |
2019-01-23 | Iniziato | UBS | Sell |
2019-01-15 | Iniziato | Argus | Buy |
2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
125,807 Shares in Elanco Animal Health Incorporated (NYSE:ELAN) Purchased by Equitable Trust Co. - MarketBeat
Veterinary Medicine Market Growth, Demand, Industry Size & - openPR
(ELAN)Analyzing Elanco Animal Health's Short Interest - Benzinga
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Veterinary Infectious Diseases Therapeutics Market Share - openPR
Private Management Group Inc. Grows Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Connect - Markets Insider
Animal Doctor: Concerns about several veterinary drug products - Washington Times Herald
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Sold by Caprock Group LLC - MarketBeat
Veterinary Eye Care Market to Grow by USD 1.05 Billion(2024-2028), Boosted by Rising Pet Ownership & Market Transformation Driven by AITechnavio - The Malaysian Reserve
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation - Markets Insider
Veterinary Wound Cleansers Market Share & Growth Forecast Report 2025-2030, with Elanco, Vetoquinol, Virbac, Innovacyn, Axio Biosolutions, Neogen, Pet Natural Remedies, Zoetis and More - Yahoo Finance
India’s Animal Healthcare Industry on a High-Growth Trajectory, Projected to Reach USD 2.0 Billion by 2034| Exclusive Report by Transparency Market Research Inc. - Yahoo Finance
Animal Parasiticides Market Witness Growth: Size, Share, - openPR
Elanco Launches Pradalex for Treatment of Livestock Respiratory Diseases - Drovers Magazine
BlackRock, Inc.'s Strategic Acquisition of Elanco Animal Health Inc Shares - GuruFocus.com
Elanco launches novel treatment for livestock respiratory diseases - Feedstuffs
Pet Pharmaceuticals Market Growth to Accelerate in Forecast - openPR
Elanco Animal Health Incorporated (NYSE:ELAN) Shares Acquired by KBC Group NV - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Reach Out - yourbigsky.com
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2024 Financial Results Announcement - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Connect - Markets Insider
Jim Cramer on Elanco Animal Health Incorporated (ELAN): ‘Not My Favorite’ - Insider Monkey
Elanco Animal Health (NYSE:ELAN) Given New $14.00 Price Target at Morgan Stanley - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Meet the Faces of Zen: Elanco’s Zenrelia™ (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal - 3BL Media
Elanco Animal demitasse Health Incorporated - The Branding Iron
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL
Veterinary Medicine Market Is Booming Worldwide 2025-2032 | - openPR
Meet the Faces of Zen: Elanco's Zenrelia(TM) (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal - Yahoo Finance
Elanco price target lowered to $14 from $15 at Morgan Stanley - MSN
2025-01-29 | Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Shareholders to Inquire about Securities Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing
ELAN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Elanco Animal Health Incorporated and Urges Investors to Contact the Firm Today! - ACCESS Newswire
Investors Who Lost Money With Elanco Animal Health Incorporated (NYSE:ELAN) Shares Should Contact the Shareholders Foundation in Connection With Lawsuit - accessnewswire.com
Meet the Faces of Zen: Elanco's Zenrelia™ (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal - PR Newswire
ELAN FRAUD NOTICE: Lose Money on Your Elanco Investment? BFA Law is Investigating the Company for Securities Fraud and Urges You to Contact the Firm (NYSE:ELAN) - ACCESS Newswire
2025-01-26 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Connect | NYSE:ELAN | Press Release - Stockhouse Publishing
ELAN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Elanco Animal Health (ELAN) Faces Investor Suit Over Zenrelia Safety ConcernsHagens Berman - ACCESS Newswire
Senior, geriatric dog care focus of new industry partnership - VeterinaryPracticeNews.com
Animal Gastroesophageal Reflux Disease Market Analysis Report 2025-2030, with Profiles of Key Players Zoetis, Merck, Elanco, Ceva, BioZyme, Annamaet Petfoods, Hill's Pet Nutrition, Blue Buffalo & More - Yahoo Finance
Now Available: Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Provides Broadest[i] Parasite Protection of Its Kind - PR Newswire
Assenagon Asset Management S.A. Sells 1,369,833 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
2025-01-22 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Reach Out | NYSE:ELAN | Press Release - Stockhouse Publishing
Jim Cramer: AMD Is A 'Great' Company, Hold Onto Dow Inc. - Benzinga
UK Veterinary Medicine Market May See a Big Move | Norbrook, Merck, Elanco - openPR
Is Elanco Animal Health Incorporated (ELAN) the Most Undervalued Stock to Invest in for Under $20? - Insider Monkey
12 Most Undervalued Stocks to Invest in for Under $20 - Insider Monkey
Top animal health companies by revenue worldwide 2023 - Statista
2025-01-19 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):